Compile Data Set for Download or QSAR
Report error Found 30 Enz. Inhib. hit(s) with all data for entry = 50013253
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564106(CHEMBL4778195)
Affinity DataIC50: 630nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM59542(SMR000523991 | cid_1088438 | MLS001201458 | 1-(4-m...)
Affinity DataIC50: 771nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564109(CHEMBL4795701)
Affinity DataIC50: 1.66E+3nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564106(CHEMBL4778195)
Affinity DataIC50: 2.56E+3nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564102(CHEMBL4791327)
Affinity DataIC50: 2.68E+3nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564107(CHEMBL4794455)
Affinity DataIC50: 3.08E+3nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564104(CHEMBL4795343)
Affinity DataIC50: 4.76E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564109(CHEMBL4795701)
Affinity DataIC50: 5.08E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564108(CHEMBL4792847)
Affinity DataIC50: 5.12E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564101(CHEMBL4792350)
Affinity DataIC50: 5.23E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564097(CHEMBL4793309)
Affinity DataIC50: 5.70E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564102(CHEMBL4791327)
Affinity DataIC50: 6.20E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50044270(CHEMBL3321852)
Affinity DataIC50: 6.20E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564098(CHEMBL4778560)
Affinity DataIC50: 8.80E+3nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564108(CHEMBL4792847)
Affinity DataIC50: 9.25E+3nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564100(CHEMBL4795393)
Affinity DataIC50: 1.06E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564098(CHEMBL4778560)
Affinity DataIC50: 1.24E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564100(CHEMBL4795393)
Affinity DataIC50: 1.33E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564103(CHEMBL4778513)
Affinity DataIC50: 1.64E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564097(CHEMBL4793309)
Affinity DataIC50: 1.77E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564107(CHEMBL4794455)
Affinity DataIC50: 2.00E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564105(CHEMBL4800550)
Affinity DataIC50: 2.29E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564099(CHEMBL4781211)
Affinity DataIC50: 2.59E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50044270(CHEMBL3321852)
Affinity DataIC50: 2.76E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564105(CHEMBL4800550)
Affinity DataIC50: 2.78E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564101(CHEMBL4792350)
Affinity DataIC50: 2.82E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564104(CHEMBL4795343)
Affinity DataIC50: 3.07E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564103(CHEMBL4778513)
Affinity DataIC50: 3.20E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 1(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM50564099(CHEMBL4781211)
Affinity DataIC50: 4.23E+4nMAssay Description:Antagonist activity at human NOD1 expressed in HEK293 cells assessed as reduction in C12-iE-DAP-induced NF-kappaB activation preincubated for 1 hr fo...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed
TargetNucleotide-binding oligomerization domain-containing protein 2(Human)
University of Ljubljana

Curated by ChEMBL
LigandPNGBDBM59542(SMR000523991 | cid_1088438 | MLS001201458 | 1-(4-m...)
Affinity DataIC50: 5.49E+4nMAssay Description:Antagonist activity at human NOD2 expressed in HEK293 cells assessed as reduction in MDP-induced NF-kappaB activation preincubated for 1 hr followed ...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/29/2022
Entry Details Article
PubMed